ACADIA Pharmaceuticals Inc. news

   Watch this stock
Showing stories 1 - 10 of about 80   

Articles published

ACAD 24.33 -0.13 (-0.53%)
price chart
Acadia Still Offers Considerable Upside Potential (ACAD)
We initially recommended the shares of Acadia Pharmaceuticals Inc. (NASDAQ: ACAD), on July 28, 2013. At that time, we noted that the stock would probably require more patience than is typical of the Event Driven Special Situations that we usually ...
Biotech Stocks Technical Insight - Incyte, Regado Biosciences, ACADIA Pharma ...
Investor-Edge has initiated coverage on the following equities: Incyte Corporation INCY, -2.32% Regado Biosciences Inc. RGDO, -1.77% ACADIA Pharmaceuticals Inc. ACAD, -1.21% Pharmacyclics Inc. PCYC, -1.39% and Raptor Pharmaceutical Corporation ...
Related articles »  
Investors dropping biotechs: BioMarin (BMRN), Incyte (INCY), Celgene (CELG ...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), Incyte Corporation (NASDAQ:INCY), Celgene Corporation (NASDAQ:CELG), ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Amgen, Inc. (NASDAQ:AMGN), Gilead Sciences, Inc. (NASDAQ:GILD) and Seattle ...
ACADIA Pharmaceuticals Inc. (ACAD) Jumps 10.97% on September 2
ACADIA Pharmaceuticals Inc. (ACAD) was among the biggest gainers on the Russell 2000 for September 2 as the stock popped 10.97% to $26.61, representing a gain of $2.63 per share.
Trend Analysis Report -Lexmark International Inc(LXK), ACADIA ...
ACADIA Pharmaceuticals Inc.(NASDAQ:ACAD)percentage change down -0.85% to close at $25.67 with the total traded volume of 1 million shares more than average volume of 1.33 million.
Today's Stocks: NVIDIA Corporation (NASDAQ:NVDA), ACADIA ...
NVIDIA Corporation (NASDAQ:NVDA) distance from 50-day simple moving average (SMA50) is -1.54%. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) Director Laura Brege sold 10,000 shares of the company's stock in a transaction that occurred on ...
Related articles »  
Stocks in the Spotlight: Sprint Corporation (S), ACADIA Pharmaceuticals Inc ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) jumped 2.80 percent to $28.24 on Friday. The company's CEO Uli Hacksell last week sold 30,000 shares of ACAD stock at an average price of $27.36 per share.
Related articles »  
Hot Watch List: ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Windstream ...
On 9 September Windstream Holdings, Inc. (NASDAQ:WIN) announced the appointments of William LaPerch and Michael Stoltz to the company's board of directors. Windstream Holdings, Inc. (NASDAQ:WIN) shares fell -1.33% in last trading session and ...
News Recap - Skechers USA Inc (NYSE:SKX), ACADIA Pharmaceuticals Inc ...
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) declared that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to NUPLAZID´┐Ż (pimavanserin) for the treatment of Parkinson's disease psychosis.
Related articles »  
Options Radar: ACADIA Pharmaceuticals, Weibo Corp, and First Solar
Option traders have taken a shine to drug maker ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), Chinese social media concern Weibo Corp (ADR) (NASDAQ:WB), and alternative energy firm First Solar, Inc. (NASDAQ:FSLR).
Watch List: Yandex N.V. (NASDAQ:YNDX), ACADIA Pharmaceuticals Inc ...  Markets Insider
Pre-market Gainers: Rocket Fuel Inc. (NASDAQ:FUEL), ACADIA ...  WallStreet Scope
Related articles »